Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer Of Prostate: early-phase trial registry
5 of 8 indexed Cancer Of Prostate trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 5 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Cancer Of Prostate: 8 US clinical trials tracked, 5 recruiting.
Cancer Of Prostate is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 4 of these trials.
Enrollment posture brief
Registry condition cancer-of-prostate
OPEN 5 | RECR 63% | LATE 0 | EARLY 3 | RANK #2176 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Adolescent (63% recruiting · 16 trials)
Cancer Of Prostate lists 5 open slots (63% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer Of Prostate on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer Of Prostate is recruiting above its size-band peers.
5 of 8 indexed trials (62.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cancer Of Prostate research.
National Cancer Institute (NCI) accounts for 4 of 8 trials (50%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer Of Prostate enrolment sits around 532 participants.
Median target enrolment is 532 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Cancer Of Prostate splits between interventional and observational designs.
4 interventional and 4 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
National Cancer Institute (NCI)
NCT03354416
Collection of Blood From Patients With Prostate Cancer
National Cancer Institute (NCI)
NCT00923221
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
National Cancer Institute (NCI)
NCT04633252
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy
National Cancer Institute (NCI)
NCT05361798
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Washington University School of Medicine
NCT04887935
Onco-primary Care Networking to Support TEAM-based Care
Duke University
NCT04258813
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
UNC Lineberger Comprehensive Cancer Center
NCT02564120
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Exosome Diagnostics
NCT03031418
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cancer Of Prostate records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer Of Prostate trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer Of Prostate page
8 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Cancer Of Prostate trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Cancer Of Prostate trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer Of Prostate condition card totals 8 registered trials; most-linked intervention M9241; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.